Unseated internal flow transducer connectors can trigger device reboots and therapy interruptions, prompting updated checkout and handling protocols.

The US Food and Drug Administration (FDA) has issued an early alert regarding a potential issue with VOCSN ventilators from Ventec Life Systems, doing business as React Health.

The notice covers all VOCSN ventilator models with serial numbers 112786 and higher, including VOCSN+Pro, VC+Pro, VOCSN, VCSN+Pro, V+Pro, V+ Pro Emergency, VC, and V*Home models.

Connector Unseating and System Fault 10 Alarms

According to React Health, the internal flow transducer cable connector inside the ventilators can become partially or fully unseated, resulting in a loss of communication with the internal flow transducer board. This physical disconnect can trigger device reboots and recurring System Fault 10 alarms.

The manufacturer identified substantial physical impacts, such as dropping the ventilator, as a primary cause of the connector coming loose. Because the internal flow transducer cable is standard across the entire VOCSN product line, the issue affects every model configuration regardless of which therapy options are activated.

If an unseated connector prompts a reboot while a patient is receiving active ventilation, the device will generate an alarm and temporarily interrupt mechanical ventilation. Such an interruption poses critical risks to ventilator-dependent patients who cannot maintain spontaneous breathing, potentially leading to serious injury, permanent impairment, or death without immediate intervention.

However, React Health reported that no reboots have occurred while a patient was actively receiving ventilation therapy, rating the probability of such an event as remote based on available complaint and investigation data. Additionally, as of August 12, 2026, no serious injuries or deaths have been linked to the defect.

In an urgent notification letter issued to customers on Sept 17, React Health outlined clinical recommendations and technical handling procedures to mitigate risks.

For healthcare technology management professionals, distributors, and clinical personnel, recommended actions include:

  • Servicing and Backup Ventilation: If any unit displays recurring reboots or System Fault 10 alarms, transition the patient to backup ventilation immediately and contact React Health for device servicing.
  • Impact Inspections: If a ventilator is dropped or sustains an impact, clinical engineering staff or caregivers must complete the formal checkout procedure in the VOCSN Series Ventilator Portfolio Clinical and Technical Manual (LBL-00001) before returning the unit to patient use.
  • Physical Security: Ensure ventilators are secured on a flat, stable surface, roll stand, or carry bag to prevent drops and shocks during hospital transport or home use.
  • Backup Availability: Confirm that secondary ventilation equipment—such as a backup ventilator or manual resuscitator—is functional, regularly inspected, and immediately accessible for all ventilator-dependent patients.
  • Downstream Notifications: Facilities, distributors, and durable medical equipment providers must promptly notify all affected caregivers, patients, or transferring facilities of the alert and supply copies of the safety notice.
  • Approved Packaging: When returning devices for evaluation or maintenance, always utilize manufacturer-approved packaging to prevent transit shocks.

The VOCSN Unified Respiratory System provides invasive and noninvasive ventilatory support in hospital, institutional, home, and transport environments for pediatric and adult patients weighing at least 5 kg.

The FDA stated it will continue to monitor the issue and provide updates as new details emerge. Healthcare professionals experiencing performance issues or adverse events are encouraged to submit reports to the FDA MedWatch program.